Glycopyrronium Tosylate Patent Expiration
Glycopyrronium Tosylate is Used for reducing excessive sweating in the underarms in adults and children 9 years of age and older. It was first introduced by Journey Medical Corp
Glycopyrronium Tosylate Patents
Given below is the list of patents protecting Glycopyrronium Tosylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qbrexza | US10004717 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US10543192 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US10548875 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US8859610 | Crystalline glycopyrrolate tosylate | Feb 28, 2033 | Journey |
| Qbrexza | US9006462 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US9259414 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US9744105 | Topical glycopyrrolate formulations | Jul 18, 2030 | Journey |
| Qbrexza | US8618160 | Topical glycopyrrolate formulations | Dec 10, 2029 | Journey |
| Qbrexza | US10052267 | Topical glycopyrrolate formulations | Oct 17, 2028 | Journey |
| Qbrexza | US6433003 | Method for treating hyperhidrosis in mammals |
Apr 10, 2020
(Expired) | Journey |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Glycopyrronium Tosylate's patents.
Latest Legal Activities on Glycopyrronium Tosylate's Patents
Given below is the list recent legal activities going on the following patents of Glycopyrronium Tosylate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 30 Jun, 2025 | US8618160 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US10052267 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US8859610 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US8618160 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US9744105 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US10543192 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US10004717 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 23 May, 2025 | US10548875 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Feb, 2025 | US9744105 |
| Requirement for information sent under 37 CFR 1.750 | 22 Jan, 2024 | US8618160 |
Glycopyrronium Tosylate's Family Patents
